Trial Phase
Trial Status
Paid Participation
Clear All
27 Ibrutinib Trials Near You
Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerTrial Details
Key Eligibility Criteria
465 Participants Needed
Ibrutinib + Stem Cell Transplant for Lymphoma
Trial Details
Key Eligibility Criteria
92 Participants Needed
Trial Details
Key Eligibility Criteria
650 Participants Needed
Combination Therapy for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
720 Participants Needed
Trial Details
Key Eligibility Criteria
533 Participants Needed
Ibrutinib + Rituximab for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
529 Participants Needed
Trial Details
Key Eligibility Criteria
547 Participants Needed
Long-term Ibrutinib for Lymphoma
Trial Details
Key Eligibility Criteria
700 Participants Needed
Extended Ibrutinib Treatment for Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
600 Participants Needed
Epcoritamab + Ibrutinib for Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
38 Participants Needed
Venetoclax + Ibrutinib for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
28 Participants Needed
Venetoclax + cBTKi for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
100 Participants Needed
Parsaclisib Combinations for B-Cell Cancers
Trial Details
Key Eligibility Criteria
112 Participants Needed
Palbociclib + Ibrutinib for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
39 Participants Needed
JCAR017 for Chronic Leukemia or Lymphoma
Trial Details
Key Eligibility Criteria
320 Participants Needed
Ibrutinib for Refractory Melanoma
Trial Details
Key Eligibility Criteria
18 Participants Needed
Ibrutinib for High-risk CLL/SLL
Trial Details
Key Eligibility Criteria
42 Participants Needed
Ibrutinib for Hairy Cell Leukemia
Trial Details
Key Eligibility Criteria
44 Participants Needed
Ibrutinib for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
154 Participants Needed
Daratumumab + Ibrutinib for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
15 Participants Needed
Trial Details
Key Eligibility Criteria
54 Participants Needed
Ibrutinib + Revlimid/Dexamethasone for Multiple Myeloma
Trial Details
Key Eligibility Criteria
14 Participants Needed
Ibrutinib + Palbociclib for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
28 Participants Needed
Lenalidomide + Ibrutinib for Lymphoma
Trial Details
Key Eligibility Criteria
39 Participants Needed
Trial Details
Key Eligibility Criteria
33 Participants Needed
Trial Details
Key Eligibility Criteria
92 Participants Needed
Ibrutinib + Venetoclax for Leukemia
Trial Details
Key Eligibility Criteria
320 Participants Needed
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.